BioCentury
ARTICLE | Company News

Bio-ID Diagnostics Inc., Trovagene deal

February 13, 2012 8:00 AM UTC

TrovaGene completed its acquisition of Bio-ID's MultiGen Diagnostics Inc. subsidiary for 750,000 shares valued at $562,500 based on TrovaGene's close of $0.75 on Feb. 7, the day before the deal closed...